We have expanded the list of climate policies we assess company engagement with to incorporate land-use related policy, referring to legislative or regulatory measures to enhance and protect ecosystems and land where carbon is being stored. Assessments under this category are currently underweighted in terms of their contribution to the overall company metrics. This weighting will be progressively increased over the next 6 months.
We adjusted the terminology used to describe the queries running down the left-hand side of our scoring matrix and added additional explanatory text to the info-boxes. This has no impact on the scores and methodology. It has been done following user feedback to improve clarity.
Climate Lobbying Overview: Japan Pharmaceutical Manufacturers Association (JPMA) appears to have very limited top-line messaging on climate policy.
Top-line Messaging on Climate Policy: In the JPMA website accessed in September 2022, JPMA appears to support sector-based target to achieve zero emission by 2050.
Engagement with Climate-Related Regulations: JPMA has no transparent positions on, or engagement with, climate-related regulations.
Positioning on Energy Transition: JPMA has no transparent positions on, or engagement with, the energy transition.